2026-10-25
Does not pass
Sol-Gel Technologies does not pass the ethical screen. The binding factor is interest/revenue 7.3%.
NAS100 29,430 −1.28%
S&P 7,718 −0.34%
GOLD $4,038 −0.34%
BTC $80,235 −1.27%
VIX 16.92 +0.06%
latest tape · as of 14:02 UTC
The Screen · Healthcare
Sol-Gel Technologies Ltd.
SLGL · Nasdaq · USD · Market cap $228M
FAIL · Does not pass the screen69.45 USD
Price as of 23 Oct 2026Daily close, not a live quoteLast reviewed 6 days ago
Screened 2026-10-23 · the tape above runs as of 14:02 UTC · two dates, stated on purpose · verdict and workings shown in full · never trimmed
Key facts today
- Price69.45 USD at the 23 Oct 2026 close
- Ethical screenDoes not pass
- Last reviewed23 Oct 2026 (6 days ago)
A summary of the dated readings below, not a live quote and not advice.
PRICE · FAIR-VALUE RANGE1M3M6MYTD1Y3Y5Y
What this means: price 69.45 against the desk's fair-value range, base estimate 138.90, over the last year.
- Trend Accumulation
- Insiders insiders bought, latest filing 2026-09-10
- Positioning no disclosures inside 60 days, left as found
- Options no verdict drawn today, left as found
- Ethical does not pass the values gate
Price69.45 USD
Fair value138.90
Our investment reviews on this name
2026-10-02Read Accumulation60.74+14.3% to today ✓Markdown gives way to Accumulation after a 13% slide in 3 weeks
2026-09-13Read Markdown69.52-0.1% to today ✓Accumulation gives way to Markdown after an 11% slide in 10 weeks
2026-07-02Read Accumulation77.98-10.9% to today First review on file: Accumulation
Our analytic regime reads on this name, dated and marked against the screened price. Small sample per name, and separate from the daily-framework accuracy on the Track Record page.
The full research record, in depth, below
This name holds its accumulation label.
Sol-Gel Technologies Ltd. holds its Accumulation at $69.45. The statistical read favours the sellers, held for 124 days.
| Phase | Accumulation |
| Quantitative state | The statistical read favours the sellers, held for 124 days |
| Price at the screen | $69.45 |
| Valuation | N/A trailing · -8.32 forward price to earnings |
| Values screen | FAIL |
| Beta | 1.15 |
Five Screens, Shown in Full
Does not pass. Interest/revenue 7.3%
| Test | Figure | Limit | What it means | Status |
|---|---|---|---|---|
| Business activity | Permissible | Core business clean | Its core business isn't built on prohibited lines: no gambling, alcohol, tobacco, weapons, or interest-based lending. | Pass |
| Debt load | 0.41% | Below 33% | Interest-bearing debt is just 0.4% of its assets, well under the one-third ceiling: it does not run on borrowed money. | Pass |
| Interest-bearing cash | 9.97% | Below 33% | Cash held in interest-bearing accounts and securities is 10.0% of assets, under the one-third limit. | Pass |
| Receivables | 0.00% | Below 49% | Money owed to the company is 0.0% of assets, under the 49% limit. | Pass |
| Revenue purity | 7.28% | Below 5% | 7.3% of revenue comes from non-compliant sources, over the 5% line. | Fail |
Five checks adapted from AAOIFI screening standards: business activity plus four balance-sheet ratios. All five must pass for ethical clearance. Every figure is arithmetic on public accounts, not judgement.
The Ethical ReadWhy It Falls Short, in Plain English
Sol-Gel Technologies does not pass the ethical screen. The binding factor is interest/revenue 7.3%.
Read as at 2026-10-28. It updates when the underlying figures move, and past reads are kept below.
2026-09-24
Clears
Sol-Gel Technologies clears all five screens. Its business is in a permissible area, its debt is near-nil, and almost none of its income is interest, so it passes.
Earlier reads, kept as written. The ethical profile is tracked over time, not overwritten.
Follow this verdict
Get an email when SLGL's ethical verdict changes
Today SLGL does not pass the screen. If new figures move it to a pass, we send you one short email with the before and after. Verdicts change rarely, so you may not hear from us for a long time.
Free, no account needed. Every email has a link to stop.
The Fair Value Range
Fair value range in USD, drawn from the 2026-10-23 screen. The gold marker is the market price at the same screen. A 100.0% margin of safety to the base estimate.
Third-party analyst targets: 2 covering, consensus Strong Buy. The average target sits +120% from the screen price.
Reading the gap · Both our model and the analysts see meaningful upside from here.
Price History & ProjectionsWhere it has been, where the models see it going. History from market close data; projection points are our fair-value estimates and third-party analyst targets, dated to the 2026-10-23 screen.
Fair value and rating are our own model estimates; the Street's range reflects third-party analyst estimates. Analysis, not advice.
The Business, in Plain Words| Forward P/E | -8.3x |
| EPS, trailing | -5.61 |
| EPS, forward | -8.36 |
| Revenue growth | -96.6%revenue is shrinking |
| Profit margin | 0.0%currently unprofitable |
| Return on equity | -40.9%not currently earning a positive return on equity |
| FCF yield | -0.93% |
| Debt to equity | 1.60a meaningful debt load worth watching |
| Current ratio | 10.37comfortably covers its short-term bills |
| Beta | 1.15moves a little more than the market |
| Short interest, float | 0.14% |
| 52-week range | 28.81 - 97.97 |
| Market cap | $228M |
The risks · The things to watch: it's a small-cap, so the share price can swing harder than the market; it carries a real debt load, which raises the stakes if revenue slips.
Plain-English interpretation of our own screen data. Analysis, not advice.
Where & How to TradeSLGL trades on Nasdaq. As a listed security it is accessible through almost any international broker offering its home market. New to this, or investing from abroad? Our guide to accessing global markets covers brokers, currencies and the practical steps.
Every Entry, As Written
2026-10-22
Accumulation $68.70
+13.1% Entry 7
The analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 13.1% since our last review. Ethical screening: FAIL. This security does not pass our values-based screening criteria. The risk-adjusted return profile shows modest positive risk-adjusted returns. Our composite framework grades it D. Technically it is momentum reading neutral. Over the past year the shares are up 964%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it strong buy, with a mean price target of $147.
2026-10-02
Accumulation · changed $60.74
-12.6% Entry 6
The framework has shifted from markdown to accumulation since the last review. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 12.6% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 42% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 964%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it strong buy, with a mean price target of $147.
2026-09-13
Markdown · changed $69.52
-21.0% Entry 5
The framework has shifted from accumulation to markdown since the last review. Price is trending lower. Sellers are in control and the prior trend has reversed. Price has moved down 21.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 42% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 964%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it strong buy, with a mean price target of $147.
2026-08-13
Accumulation $88.00
+12.8% Entry 4
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved up 12.8% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 42% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 964%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it strong buy, with a mean price target of $147.
2026-07-18
Accumulation $77.98
+0.0% Entry 3
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns. Our composite framework grades it B. Technically it is holding around 42% above its long-term trend line with momentum reading neutral. Over the past year the shares are up 964%. Our forward projection puts the odds of a 10% gain over the next month near 42%. The street (2 analysts) rates it strong buy, with a mean price target of $147.
2026-07-03
Accumulation $77.98
+0.0% Entry 2
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Price has moved down 0.0% since our last review. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
2026-07-02
Accumulation $77.98
Entry 1
Our analysis reads accumulation. Smart money appears to be quietly building positions. This typically precedes a markup phase. Ethical screening: PASS with ethical screening pending. The risk-adjusted return profile shows excellent risk-adjusted returns.
Each entry above was written on its date, before the outcome. A journal you can prune is not a journal.
- SolGel Technologies (SLGL) Upgraded to Buy: Here's Why Yahoo Finance · 21d ago
- Sol-Gel Technologies to Host KOL Investor Day for SGT-610 on October 14, 2026 Yahoo Finance · 29d ago
- SolGel Technologies (SLGL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? Zacks · 17 Sep 2026
- SolGel Technologies (SLGL) Forms 'Hammer Chart Pattern': Time for Bottom Fishing? Yahoo Finance · 17 Sep 2026
- Sol-Gel Technologies Announces Last Patient Last Visit in Pivotal Phase 3 Clinical Trial of SGT-610 in Gorlin Syndrome Yahoo Finance · 17 Sep 2026
Headlines from third-party outlets, linked for reference: not our reporting, not advice.
KROSKeros Therapeutics, Inc.
GLSIGreenwich LifeSciences, Inc.
SMTISanara MedTech Inc
RXSTRxSight Inc
TARAProtara Therapeutics Inc
SYSo-Young International Inc.
Screened names in the same industry · explore each on its own page.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-10 | Opaleye Management Inc. | 10% | P - Purchase | 3,124 | $207,399 |
| 2026-07-01 | Opaleye Management Inc. | 10% | Purchase | 1,712 | $0 |
| 2026-05-13 | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 3,437 | $231,502 | |
| 2026-03-24 | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 39,665 | $2,855,880 | |
| 2026-02-13 | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 291 | $18,333 | |
| 2026-02-02 | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 100 | $5,800 | |
| 2026-02-02 | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 100 | $5,800 | |
| 2026-01-27 | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 100 | $5,705 | |
| 2026-01-23 | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 3,324 | $187,356 | |
| 2026-01-05 | OPALEYE MANAGEMENT, INC. | Beneficial Owner of more than 10% of a Class of Security | 2,592 | $108,858 |
Public filings, recorded as found. The full tape lives at Insider Intelligence.
| Period | Price then | Price return | Divs per share | $1,000 became | Total return |
|---|---|---|---|---|---|
| 1 month | $69.98 | +5.0% | · | $1,050 | +5.0% |
| 2 months | $74.86 | -1.8% | · | $982 | -1.8% |
| 3 months | $85.31 | -13.8% | · | $862 | -13.8% |
| 6 months | $42.30 | +73.8% | · | $1,738 | +73.8% |
| 1 year | $6.91 | +963.7% | · | $10,637 | +963.7% |
| 2 years | $7.70 | +854.6% | · | $9,546 | +854.6% |
| 3 years | $33.50 | +119.4% | · | $2,194 | +119.4% |
| 5 years | $112.70 | -34.8% | · | $652 | -34.8% |
Historical returns from market close data. Past performance does not guarantee future results.
This entry now belongs to the ledger. Whatever SLGL does next, these words stay.
Membership
Thirteen thousand names carry this page. One desk keeps them honest.
Membership opens the full screen archive, the composites built from it, and the daily coverage that prices what the screen approves.
Join the deskScreening is research, not a fatwa and not financial advice. Figures are drawn from public accounts at the screen date shown. Always manage your risk.